CN
Infectious Disease

Overview

Our Infectious Disease team provides world class services to accelerate your drug discovery process from target validation to PCC nomination.

The outstanding infrastructure and instrumentation allow us to conduct high quality researches both in vitro and in vivo for our clients.

  • BSL-2 facilities (>3,500 ft2), antiviral & antibacterial
  • ABSL-2 facilities (~3,000 ft2, 6 animal rooms, holding capacity of 5,000 rodents, ALAAAC accredited), antiviral & antibacterial
  • State-of-art instrumentation (e.g. COBAS system, POD810, Luminex, FACS, etc.)

 

Business Contact